Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Adherence, compliance and concordance

Cochrane researchers call for better ways of studying medicines adherence

Methods to improve patients’ adherence to medicines are generally unproven and there is an urgent need to develop more effective approaches, say the authors of a Cochrane review[1].

Although they identified 182 trials testing interventions to enhance drug adherence, effects were inconsistent and most trials were poor quality.

“The studies varied so much in terms of their design and their results that it would have been misleading to try to come up with general conclusions,” says lead researcher, Robby Nieuwlaat from McMaster University, Hamilton, Canada. “It is uncertain how adherence to medication can be consistently improved. We need to see larger and higher quality trials, which better take into account individual patient’s problems.”

Patients may take only some of their prescribed doses; many stop taking medication altogether and others fail to follow instructions.

Nieuwlaat’s team undertook a systematic review of interventions to improve adherence; just 17 of the 182 randomised controlled trials identified were considered high quality. These generally involved complex interventions, such as tailored ongoing support from pharmacists.

Of the 17 high-quality trials, five found that the intervention led to improvements in both medicines adherence and health outcomes; no common intervention characteristics were apparent, say the authors. Even the most effective interventions had only a modest impact on adherence and clinical outcomes.

“We need more advanced methods for researching ways to improve medicines adherence, including better interventions, better ways of measuring adherence, and studies that include sufficient patients to draw conclusions on clinically important effects,” the researchers conclude.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20067257

Readers' comments (1)

  • Agreed, adherence is difficult to measure objectively without having an effect on the parameter under observation.

    The RPS guidance on the use of multi-compartment compliance aids decrys the paucity of evidence and studies to support their use - in reality, there is little good evidence to support a positive effect on adherence as stated in this article - hence the guidance is flawed.

    Unsuitable or offensive? Report this comment

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.